A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

April 26, 2024

Study Completion Date

May 24, 2024

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

Lemborexant

Lemborexant oral tablet.

OTHER

PBO

Lemborexant-matched PBO tablet.

Trial Locations (9)

5278

Kyung Hee University Hospital at Gangdong, Seoul

13620

Seoul National University Bundang Hospital, Seongnam-si

16247

The Catholic University of Korea, St. Vincent Hospital, Suwon

21565

Gacheon University Gil Medical Centre, Incheon

42601

Keimyung University Dongsan Hospital, Daegu

03080

Seoul National University Hospital, Seoul

05030

Konkuk University Medical Center, Seoul

06351

Samsung Medical Center, Seoul

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY